MRK dividend yield: 3.25%. NNN dividend yield: 5.28%. Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s. NNN REIT (formerly National Retail Properties) is a Dividend King with 34+ consecutive years of dividend increases — one of only three REITs to achieve this status. Focuses on single-tenant properties with long-term net leases to operators in necessity-based retail sectors.
Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
NNN REIT (formerly National Retail Properties) is a Dividend King with 34+ consecutive years of dividend increases — one of only three REITs to achieve this status. Focuses on single-tenant properties with long-term net leases to operators in necessity-based retail sectors.
MRK currently offers a 3.25% yield (3.08/share/year) while NNN offers 5.28% (2.26/share/year). NNN provides higher current income. However, MRK has grown its dividend faster (8.2% 5Y CAGR), which may lead to better long-term income through compounding.
How much would $10,000 in MRK vs NNN earn per year?
With $10,000 invested today: MRK pays approximately $325/year. NNN pays approximately $528/year. With DRIP reinvestment over 10 years, these grow to $950/year (MRK) and $1,148/year (NNN).
Does MRK or NNN pay monthly dividends?
MRK pays quarterly dividends. NNN pays quarterly dividends. Neither pay monthly — both use a quarterly schedule, which is preferred by investors who need regular cash flow.
📬
Get this MRK vs NNN comparison by email
Save your analysis + get weekly dividend insights. Free forever.